Brokers Set Expectations for CLDX FY2026 Earnings
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Celldex Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the biopharmaceutical company will earn ($4.68) per share for the year. The consensus estimate […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings estimates for Celldex Therapeutics in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst K. Kluska expects that the biopharmaceutical company will earn ($4.68) per share for the year. The consensus estimate […]
-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
